Navigation Links
UIC in NIH-funded islet transplantation study for type 1 diabetes
Date:7/8/2008

The University of Illinois at Chicago is one of 11 centers in the United States, Canada, Sweden and Norway to participate in the Clinical Islet Transplant Consortium funded by the National Institutes of Health.

Consortium researchers have begun clinical studies to test new approaches to islet transplantation that may lead to improved outcomes and fewer side effects for adults with difficult-to-control type 1 diabetes.

Patients with type 1 diabetes depend on multiple daily insulin injections or an insulin pump because their own immune system destroys the insulin-producing cells of the pancreas. They often develop life-threatening complications, including damage to the heart and blood vessels, eyes, nerves and kidneys.

Islet transplantation offers the most promise for achieving insulin independence, glucose control and freedom from hypoglycemic attacks for type 1 diabetics, says Dr. Jos Oberholzer, principal investigator and director of cell and pancreas transplantation at UIC.

"This research will help us find the most effective combination of anti-rejection drugs to maximize islet engraftment while reducing toxic side effects," said Oberholzer.

"The ultimate goal is to refine islet transplantation and generate an unlimited supply of islets so that many more people would benefit from this treatment," he said.

Islet transplantation involves isolating islets from a donor pancreas and infusing the cells into the main blood vessel in the patient's liver. If the transplant is successful, the islets lodge in the small blood vessels of the liver and begin producing insulin. Patients must take drugs to suppress their immune system and prevent rejection of the islets. In some cases, patients require more than one infusion of donor islets to produce enough insulin.

At UIC, patients will be enrolled in three protocols to evaluate a combination of different medications to protect the newly transplanted islet cells.


'/>"/>

Contact: Sherri McGinnis Gonzalez
smcginn@uic.edu
312-996-8277
University of Illinois at Chicago
Source:Eurekalert

Related medicine news :

1. NIH-funded Vanderbilt Research Seeks Ways to Avoid Information Overload in Health Care Choices Among Seniors
2. The new source of islet cells
3. Living donors may be best source of insulin-producing islets for diabetes treatment
4. Studies test new approaches to islet transplantation
5. Islet Cell Transplants Aid Type 1 Diabetics
6. Promising advances in islet cell transplants for diabetes
7. A rare association: Non-islet cell tumor hypoglycemia
8. American Society of Transplantations Past President Testifies Before Congress at Forum on Organ Donation
9. Patients over age 60 do well after liver transplantation
10. No racial differences seen in outcomes after liver transplantation
11. Predicting survival after liver transplantation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was ... his family verbally and physically. , “When something upset him, he couldn’t control his emotions,” ... He would throw rocks at my other children and say he was going to kill ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, ... and the Road To Recovery® program to drive cancer patients to and from their ... to ensure the highest quality of life and ongoing independence. Getting to and ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty Network, affiliated ... Weintraub as a prominent plastic surgeon and the network’s newest partner. , ... most handsome men, look naturally attractive. Plastic surgery should be invisible.” He stands ...
(Date:6/24/2016)... ... ... Venture Construction Group (VCG) sponsors Luke’s Wings 5th Annual ... Country Club at 1201 Rockville Pike, Rockville, Maryland, 20852. The event raised funds ... been wounded in battle and their families. Venture Construction Group is a 2016 Silver ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016   Pulmatrix, Inc ., (NASDAQ: ... innovative inhaled drugs, announced today that it was added ... reconstituted its comprehensive set of U.S. and global ... is an important milestone for Pulmatrix," said Chief Executive ... awareness of our progress in developing drugs for crucial ...
(Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on the ... announced that patient enrollment in its ongoing randomized ... has exceeded 50% of its 24-patient target. Capricor ... the third quarter of 2016, and to report ...
Breaking Medicine Technology: